COPD: problems in diagnosis and measurement Source: Eur Respir J 2003; 21: 4S-12S Year: 2003
Follow-up of patients with severe asthma by noninvasive parameters of airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 52s Year: 2001
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006
Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Treatment of acute asthma Source: Eur Respir Mon 2012; 56: 172-187 Year: 2012
Evaluation and management of difficult-to-control asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation Source: Eur Respir Rev 2015; 24: 204-215 Year: 2015
Roles of bronchoscopy and noninvasive measurements of airway inflammation in evaluating chronic cough: the role of noninvasive measurements of airway inflammation Source: Annual Congress 2007 - PG23 - Managing chronic cough: guidelines and controversies (jointly organised with ACCP) Year: 2007
Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005
Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
Is there any day variability of respiratory function and airway inflammation in children with mild asthma? Source: Eur Respir J 2006; 28: Suppl. 50, 264s Year: 2006
The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline Source: Annual Congress 2005 - Therapeutic options for COPD: present and future Year: 2005
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Influence of obesity on pulmonary function (PF) in severe asthmatic children Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011